A Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of NKF-PEG, and US-Neulasta in Healthy Adult Male Volunteers
Clinical trial NCT07738991 · RECRUITING
Trial details
- NCT number
- NCT07738991
- Sponsor
- Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-03
- Primary completion
- 2026-11-09
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.